Cargando…
Human pancreatic cancer cell lines do not express receptors for somatostatin.
The in vivo administration of somatostatin (SS) or its analogues is capable of suppressing the growth of pancreatic cancer in experimental animals. We examined the effects of SS-14 and its analogue RC-160 on the in vitro growth of two human pancreatic cancer cell lines MiaPaCa-2 and Panc-1 stimulate...
Autores principales: | Gillespie, J., Poston, G. J., Schachter, M., Guillou, P. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977926/ https://www.ncbi.nlm.nih.gov/pubmed/1355659 |
Ejemplares similares
-
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
por: Gillespie, J., et al.
Publicado: (1993) -
Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer
por: SHI, XUEFEI, et al.
Publicado: (2013) -
Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.
por: Evans, A. A., et al.
Publicado: (1997) -
Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer
por: Jorand, Raphael, et al.
Publicado: (2016) -
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)